Responses

other Versions

PDF
Original research
Intra-arterial vasodilators for vasospasm following aneurysmal subarachnoid hemorrhage: a meta-analysis
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

  • Published on:
    The Authors' response to "Intra-arterial vasodilators for vasospasm following aneurysmal subarachnoid hemorrhage"
    • Anand Venkatraman, Neurologist Massachusetts General Hospital/Brigham and Women's hospital/Harvard Medical School
    • Other Contributors:
      • Gyanendra Kumar, Neurologist

    We appreciate the interest shown by Drs. Yao and You (1) in our paper (2) and find it our pleasure to address their concerns.

    The first point raised by Drs. Yao and You is that our search strategy missed two articles, namely those of Mortimer et al (2015) (3) and Morgan et al (1996) (4). We would like to reassure Drs. Yao and You that we did screen these articles, and decided against including them in our meta-analysis based on our inclusion criteria. The article by Mortimer et al (2015) (3) describes a patient population where balloon angioplasty, verapamil, and papaverine infusions were used separately or in various combinations. They did not break down their results by the specific intra-arterial vasodilator (IAD) used, and therefore we decided not to include this information. The paper by Morgan et al (1996) (4) describes a patient population which overlapped with that described by the same group in another paper, Morgan et al (2000) (5). We had personally communicated with the authors in 2016 regarding the multiple papers from this group, such as Little et al (1994) (6) and Morgan et al (2000)
    (5) that described papaverine infusions for vasospasm. We found out that there were overlaps in these study populations, and that the cohort in the 2000 paper(5) was the most complete. Therefore, only this paper was included in our meta-analysis, while the earlier ones were excluded.

    The second suggestion by Drs. Yao and You was to perform a regression ana...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Intra-arterial vasodilators for vasospasm following aneurysmal subarachnoid hemorrhage
    • Zhong Yao, neurosurgeon Department of Neurosurgery, West China Hospital, Sichuan university, Chengdu, China
    • Other Contributors:
      • Chao You, neurosurgeon

    With great interest, we read the article of Venkatraman et al.[1] published in the Journal of NeuroInterventional Surgery recently. They presented a comprehensive picture depicting the effect of intra-arterial vasodilators (IADs) on the vasospasm following aneurysmal subarachnoid hemorrhage. But we were concerned with several questions weakening the reliability and generalization of the meta-analysis.
    Firstly , though the detailed including criteria and searching strategy were provided in their meta-analysis, at least two eligible studies2,3 were missed which conformed to their including criteria and unfulfilled the excluding criteria. Two cohort studies of Morgan [2] and Mortimer [3] reported the effects of IADs on vasospasm with documentation of interested events, which should be included in Venkatraman’s analysis. Whether addition of these two studies could change the overall effect of IADs was unclear, but including any eligible study was in accordance with PRISMA principle.
    Secondly, owing to the large number of included studies, the heterogeneity was substantial. Venkatraman et al.[1] conducted subgroup and sensitivity analyses, in which the heterogeneity remained significant (most values of I2 greater than 50%). It was rationale to turn to regression analyses in order to find and solve the heterogeneity.
    Besides, this article included studies combining IADs with balloon angioplasty, which might overestimate effectiveness of IADs. IADs w...

    Show More
    Conflict of Interest:
    None declared.